Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II trial of EG 011 in patients with angina pectoris.

Next Previous
Trial Profile

Phase I/II trial of EG 011 in patients with angina pectoris.

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 May 2012

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs EG 011 (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Sponsors Ark Therapeutics

    • Most Recent Events

    • 16 May 2012 The phase I dose-ranging component of the trial has completed enrolment; enrolment in the phase IIa stage of the trial is expected to begin in the third quarter of 2012 according to an Ark Therapeutics media release.
    • 18 May 2011 Recruitment into the low-dose group has been completed and several patients have been treated with the high dose, according to an Ark Therapeutics media release.
    • 28 Jan 2010 The first patient has been enrolled and treated according to an Ark Therapeutics media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top